The reduction in hepatic fibrosis may be connected with reductions in transforming growth factor beta (TGF-β) and tumor necrosis factor-alpha (TNF-α) levels, especially the former, which plays an important role in the progression from NAFLD to non-alcoholic steatohepatitis. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.